Job Advertisement Leibniz-HKI-60/2021
The Leibniz Institute for Natural Product Research and Infection Biology – Hans Knöll Institute – (Leibniz-HKI, www.leibniz-hki.de) investigates the pathobiology of human-pathogenic fungi and identifies targets for the development of novel natural product-based antibiotics. The research group of Translational Infection Medicine invites talented and highly gifted candidates to apply as as a
Staff Scientist (f/div/m) Infection Biology
starting from January 2022 at the earliest for 5 years.
The research group Translational Infection Medicine is seeking a highly motivated staff scientist with preferably over 5 years of experience in performing and managing animal research projects. The offered position is within a highly collaborative and dynamic group aiming at performing highest quality research. The successful candidate will mainly work as a staff scientist and laboratory manager and will have an integral role within the lab that is expected to also support and participate in the science. A substantial part of the work will consist of the organization of the group at all levels, including managing the day-to-day activities and budgets, support in grant writing, project/funding scoping, data generation, analysis, and reporting, inventory management, maintenance and enforcement of compliance with all safety policies and regulations (biohazard and annual environmental health & safety inspection), serving as the biosafety and gene safety responsible, status report and manuscript preparations, etc. amongst others. A special emphasis of the work will be put in managing the in vivo experiments including planning, writing and maintaining of animal welfare approvals, oversee breeding and crossing of transgenic animals, hands-on support with rodents to support the timely completion and success of research projects.
Master or PhD degree in immunology, biology, biochemistry, medicine or related life sciences
Self-motivation and team-oriented working attitude
Excellent organizational, communication, computer and record-keeping skills
Familiarity with electronic lab data management tools
Experience with animal experimentation, FELASA B/C or equivalent course
Knowledge in working with GVOs, preferably with training in Biological Safety and Gene Technology Practices
General knowledge about infection biology and immunology
Fluency in German and English are mandatory
An interesting, interdisciplinary job in the field of infection biology/immunology/host pathogen interaction with a long-term work contract
State-of-the-art equipment at an internationally renowned research institute in close cooperation with the Jena University Hospital
Support for further qualifications at the institute and by attending courses offered by the Graduate Academy of the Friedrich Schiller University Jena
Flexible working hours and a family-friendly working environment with a variety of offers for families
The successful candidate will be hosted in the research group of Translational Infection Medicine of Prof. Dr. Sebastian Weis. The Leibniz-HKI is embedded in the outstanding scientific environment of the Beutenberg Campus providing state-of-the-art research facilities and a highly integrative network of life science groups. We offer a multifaceted scientific project with excellent technical facilities, a place in a dynamic, committed team, as well as strong scientific collaborations.
Salary is paid according to German TV-L (salary agreement for public service employees). As an equal opportunity employer, the Leibniz-HKI is committed to increasing the percentage of female scientists and therefore especially encourages them to apply.
For further information:
Prof. Dr. Sebastian Weis | +49 3641 532 1011 | email@example.com
Complete applications in English should include a cover letter, a CV containing a complete list of publications, a brief statement of research experiences, the addresses of two possible referees, and should be submitted via the Leibniz-HKI online application system. The deadline for the advertisement is January 11, 2022, but applications will be reviewed on a rolling basis.